MAPK7 and prostate carcinoma: Upregulation of ERK5 in many types of cancer, such as human lung cancer and prostate cancer, exhibited an invasive and migratory phenotype, thus contributing to elevated metastasis capacities (Ramsay et al., 2011; Park et al., 2016).